Regulatory hub · UK status
Semaglutide: UK regulatory status
Also known as: Wegovy, Ozempic, Rybelsus
Last reviewed . Editorial commentary, not legal advice.
AI-friendly summary · Semaglutide
As of July 2026, semaglutide is a Prescription Only Medicine in the UK with MHRA marketing authorisation for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). It is not a controlled drug. POM advertising rules apply, restated by MHRA, ASA and GPhC in a joint warning on 18 June 2026.
Misuse of Drugs Act 1971
Semaglutide does not appear on any schedule of the Misuse of Drugs Act 1971.
Psychoactive Substances Act 2016
Semaglutide is not covered by the Psychoactive Substances Act 2016.
MHRA and medicines classification
As of July 2026, semaglutide is a Prescription Only Medicine. Wegovy is licensed for chronic weight management; Ozempic and Rybelsus are licensed for type 2 diabetes. Dispensed through registered UK pharmacies on a valid prescription. The licensed position moved twice in 2026: MHRA approved a single-dose 7.2mg Wegovy pen on 14 April 2026, and on 3 July 2026 granted conditional approval for Wegovy to treat MASH in adults with moderate to advanced liver fibrosis. MHRA has issued enforcement notices to UK sellers marketing unlicensed semaglutide for weight loss, and on 13 May 2026 the High Court ordered six UK internet providers to block websites selling counterfeit and unlicensed semaglutide.
WADA Prohibited List position
Semaglutide is not currently named on the WADA Prohibited List. Tested athletes should consult WADA and their federation directly.
ASA advertising framing
POM advertising to the public is prohibited under the Human Medicines Regulations 2012. ASA has upheld multiple rulings against UK clinics naming Wegovy or Ozempic in paid promotion.
Primary sources
- · MHRA warning on unlicensed weight-loss medicines
- · MHRA: single-dose 7.2mg semaglutide (Wegovy) pen approved, 14 April 2026
- · MHRA: semaglutide (Wegovy) approved to treat a form of liver disease, 3 July 2026
- · High Court website-blocking order, 13 May 2026
- · MHRA Products database
When in doubt about your specific position, consult MHRA directly via the MHRA contact page or seek qualified UK medicines law advice.
Frequently asked questions
Is Semaglutide legal in the UK?
What is the MHRA position on Semaglutide?
Is Semaglutide on the WADA Prohibited List?
What can UK sellers say about Semaglutide in adverts?
Related: Semaglutide editorial entry · UK regulatory hub.